Inovio’s upside hinges on INO-3107 for HPV-6/11 RRP with FDA PDUFA Oct 2026, regulatory risk, tight cash, and cheap EV. Check ...
Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...
Ditto, the pioneer in edge computing and peer-to-peer data synchronization, maker of the industry-leading edge-native mobile ...
Camilo Artiga-Purcell flags up some of the cybersecurity, data protection and privilege risks associated with client-intake ...
Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- ...
Microsoft’s investigation into RedVDS services and infrastructure uncovered a global network of disparate cybercriminals ...
Anthropic has denied reports of banning legitimate accounts, after a viral post on X claimed the creator of Claude banned the ...
Daily Express US on MSN
Mystery Havana virus device cost at least $10,000,000 and fits in a bag
"The room is literally spinning. I'm about to be sick. Ears were ringing, headache... And so I just stumbled around the room, ...
A sophisticated threat actor that uses Linux-based malware to target telecommunications providers has recently broadened its ...
Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality ...
5d
Pacira BioSciences: Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback